Niro Ramachandran's most recent trade in Akoya Biosciences Inc was a trade of 151,930 Common Stock done . Disclosure was reported to the exchange on July 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 151,930 | 130,625 | - | - | Common Stock | |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 130,625 | 0 | - | - | Common Stock | |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 70,000 | 0 | - | - | Employee Stock Option (Right t | |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 62,566 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 62,566 | 324,703 | - | - | Common Stock | |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 45,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 45,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Jul 2025 | 42,148 | 282,555 | - | - | Common Stock | |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.70 per share. | 23 Mar 2025 | 2,310 | 287,210 | - | 1.7 | 3,927 | Common Stock |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. | 01 Mar 2025 | 3,594 | 289,520 | - | 1.6 | 5,858 | Common Stock |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. | 01 Mar 2025 | 2,310 | 293,114 | - | 1.6 | 3,765 | Common Stock |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2024 | 87,500 | 295,424 | - | 0 | Common Stock | |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.79 per share. | 23 Mar 2024 | 2,006 | 207,924 | - | 4.8 | 9,609 | Common Stock |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 35,000 | 212,235 | - | 0 | Common Stock | |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.03 per share. | 22 Feb 2024 | 2,305 | 209,930 | - | 6.0 | 13,899 | Common Stock |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.69 per share. | 23 Mar 2023 | 1,945 | 177,235 | - | 7.7 | 14,957 | Common Stock |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 45,000 | 45,000 | - | - | Employee Stock Option (Right to Buy) | |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 22,500 | 179,180 | - | 0 | Common Stock | |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 34,000 | 62,566 | - | - | Employee Stock Option (Right to Buy) | |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.91 per share. | 15 Feb 2023 | 34,000 | 156,680 | - | 0.9 | 30,940 | Common Stock |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.91 per share. | 13 Apr 2022 | 75,107 | 122,680 | - | 0.9 | 68,347 | Common Stock |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2022 | 75,107 | 96,566 | - | - | Employee Stock Option (Right to Buy) | |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 13.13 per share. | 19 Nov 2021 | 25,000 | 25,073 | - | 13.1 | 328,293 | Common Stock |
| Akoya Biosciences Inc | Niro Ramachandran | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 12.85 per share. | 19 Nov 2021 | 73 | 73 | - | 12.8 | 938 | Common Stock |